Tech Company Financing Transactions
CardioSignal Funding Round
DigiTx Partners, Maki.vc and Sandwater invested in a $10 million Series A funding round for CardioSignal. The round was announced by the company on 1/15/2024.
Transaction Overview
Company Name
Announced On
1/15/2024
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Aurakatu 6
Turku, 20100
Finland
Turku, 20100
Finland
Phone
Undisclosed
Website
Email Address
Overview
CardioSignal is a brand and a product by Precordior. We are a health technology company based in United States and Finland. Originally an academic spinoff, we have over a decade of research and algorithm development as basis. Our roots are in Turku, Finland, where researchers discovered that motion sensors found in modern smartphones could be harnessed for heart disease detection.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Juuso Blomster
Chief Operating Officer
Tuomas Valtonen
Chief Technical Officer
Marko Mattila
President
Tero-Pekka Alastalo
VP - Marketing
Juulia Simonen
VP - R & D
Kristiina Santalahti
Browse more venture capital transactions:
Prev: 1/15/2024: Spot Technologies venture capital transaction
Next: 1/15/2024: Thema venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs